These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1451 related articles for article (PubMed ID: 24583165)

  • 21. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders.
    Thauvin-Robinet C; Munck A; Huet F; de Becdelièvre A; Jimenez C; Lalau G; Gautier E; Rollet J; Flori J; Nové-Josserand R; Soufir JC; Haloun A; Hubert D; Houssin E; Bellis G; Rault G; David A; Janny L; Chiron R; Rives N; Hairion D; Collignon P; Valeri A; Karsenty G; Rossi A; Audrézet MP; Férec C; Leclerc J; Georges Md; Claustres M; Bienvenu T; Gérard B; Boisseau P; Cabet-Bey F; Cheillan D; Feldmann D; Clavel C; Bieth E; Iron A; Simon-Bouy B; Izard V; Steffann J; Viville S; Costa C; Drouineaud V; Fauque P; Binquet C; Bonithon-Kopp C; Morris MA; Faivre L; Goossens M; Roussey M; Girodon E;
    J Med Genet; 2013 Apr; 50(4):220-7. PubMed ID: 23378603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
    Stanke F; Ballmann M; Bronsveld I; Dörk T; Gallati S; Laabs U; Derichs N; Ritzka M; Posselt HG; Harms HK; Griese M; Blau H; Mastella G; Bijman J; Veeze H; Tümmler B
    J Med Genet; 2008 Jan; 45(1):47-54. PubMed ID: 18178635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles.
    Terlizzi V; Castaldo G; Salvatore D; Lucarelli M; Raia V; Angioni A; Carnovale V; Cirilli N; Casciaro R; Colombo C; Di Lullo AM; Elce A; Iacotucci P; Comegna M; Scorza M; Lucidi V; Perfetti A; Cimino R; Quattrucci S; Seia M; Sofia VM; Zarrilli F; Amato F
    J Med Genet; 2017 Apr; 54(4):224-235. PubMed ID: 27738188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CFTR genotypes in patients with normal or borderline sweat chloride levels.
    Feldmann D; Couderc R; Audrezet MP; Ferec C; Bienvenu T; Desgeorges M; Claustres M; Mittre H; Blayau M; Bozon D; Malinge MC; Monnier N; Bonnefont JP; Iron A; Bieth E; Dumur V; Clavel C; Cazeneuve C; Girodon E
    Hum Mutat; 2003 Oct; 22(4):340. PubMed ID: 12955726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for cystic fibrosis: the importance of using the correct tools.
    Shah U; Moatter T
    J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
    Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
    Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic fibrosis mutations with widely variable phenotype: the D1152H example.
    Mussaffi H; Prais D; Mei-Zahav M; Blau H
    Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Borderline sweat test: Utility and limits of genetic analysis for the diagnosis of cystic fibrosis.
    Seia M; Costantino L; Paracchini V; Porcaro L; Capasso P; Coviello D; Corbetta C; Torresani E; Magazzù D; Consalvo V; Monti A; Costantini D; Colombo C
    Clin Biochem; 2009 May; 42(7-8):611-6. PubMed ID: 19318035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse genotypical features and impacts on clinical course and severity of cystic fibrosis: early childhood experience.
    Halicioglu O; Akman SA; Sutcuoglu S; Coker I
    Minerva Pediatr; 2011 Jun; 63(3):169-75. PubMed ID: 21654597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CFTR gene mutations in adults with disseminated bronchiectasis.
    Girodon E; Cazeneuve C; Lebargy F; Chinet T; Costes B; Ghanem N; Martin J; Lemay S; Scheid P; Housset B; Bignon J; Goossens M
    Eur J Hum Genet; 1997; 5(3):149-55. PubMed ID: 9272738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
    Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relations between the frequency of the DeltaF 508 mutation and the course of pulmonary disease in cystic fibrosis patients infected with Pseudomonas aeruginosa.
    Rosenecker J
    Eur J Med Res; 2000 Aug; 5(8):356-9. PubMed ID: 10958769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysis.
    Naguib ML; Schrijver I; Gardner P; Pique LM; Doss SS; Abu Zekry MA; Aziz M; Nasr SZ
    J Cyst Fibros; 2007 Apr; 6(2):111-6. PubMed ID: 16837250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.